C World Wide Group Holding A Clovis Oncology, Inc. Transaction History

C World Wide Group Holding A

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 02, 2019	SELL	$12.81 - $25.67 $813,819 - $1.63 Million	-63,530 Closed	0 $0
Q1 2019 May 03, 2019	SELL	$17.66 - $30.28 $87,628 - $150,249	-4,962 Reduced 7.24%	63,530 $1.58 Million
Q4 2018 Feb 12, 2019	SELL	$11.63 - $32.67 $263,582 - $740,432	-22,664 Reduced 24.86%	68,492 $1.23 Million
Q3 2018 Nov 05, 2018	SELL	$29.37 - $49.48 $447,863 - $754,520	-15,249 Reduced 14.33%	91,156 $2.68 Million
Q2 2018 Aug 03, 2018	SELL	$42.06 - $62.4 $1.26 Million - $1.87 Million	-29,943 Reduced 21.96%	106,405 $4.84 Million
Q1 2018 May 03, 2018	SELL	$50.12 - $67.72 $1.67 Million - $2.26 Million	-33,352 Reduced 19.65%	136,348 $7.2 Million
Q4 2017 Feb 07, 2018	SELL	$57.69 - $84.58 $2.36 Million - $3.46 Million	-40,927 Reduced 19.43%	169,700 $11.5 Million
Q3 2017 Nov 06, 2017	BUY	$67.17 - $84.81 $14.1 Million - $17.9 Million	210,627	210,627 $17.4 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

Stay updated on C World Wide Group Holding A with notifications on news.